v3.26.1
Share-Based Payments (Tables)
12 Months Ended
Jan. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Option Pricing Assumptions The weighted average assumptions used in the Black-Scholes option-pricing model and weighted-average grant date fair value for options granted in 2025, 2024, and 2023 are as follows:
Years Ended
January 30, 2026January 31, 2025February 2, 2024
Weighted-average assumptions used:
Expected volatility31.4 %31.6 %32.2 %
Dividend yield1.80 %1.79 %1.74 %
Risk-free interest rate4.03 %4.33 %3.59 %
Expected term, in years7.007.006.50
Weighted-average grant date fair value$77.51 $84.76 $64.41 
Schedule of Stock Option Activity
Transactions related to stock options for the fiscal year ended January 30, 2026, are summarized as follows:
(in thousands, except per share and years data)SharesWeighted-Average Exercise Price Per ShareWeighted-Average Remaining TermAggregate Intrinsic Value
Outstanding as of January 31, 20251,625 $150.23 
Granted138 234.01 
Canceled, forfeited or expired(4)200.43 
Exercised(181)115.75 
Outstanding as of January 30, 20261,578 $161.38 5.42$166,736 
Vested and expected to vest as of January 30, 20261
1,572 $161.09 5.41$166,533 
Exercisable as of January 30, 20261,278 $145.59 4.73$155,227 
1    Includes outstanding vested options as well as outstanding nonvested options after a forfeiture rate is applied.
Schedule of Restricted Stock Awards Activity
Transactions related to restricted stock awards for the fiscal year ended January 30, 2026, are summarized as follows:
(in thousands, except per share data)SharesWeighted-Average Grant-Date Fair Value Per Share
Nonvested as of January 31, 20251,277 $224.15 
Granted764 234.64 
Vested(567)215.22 
Canceled or forfeited(119)232.46 
Nonvested as of January 30, 20261,355 $233.07 
Schedule of Awards Granted Deferred stock units granted to non-employee Directors in 2025, 2024, and 2023 are as follows:
Years Ended
(In thousands, except per share data)January 30, 2026January 31, 2025February 2, 2024
Deferred shares granted to non-employee Directors111211
Weighted-average grant date fair value per share$225.73 $221.29 $206.52 
Schedule of Performance Share Units Pricing Assumptions
The weighted-average assumptions used in the Monte Carlo simulations for these awards granted in 2025, 2024, and 2023 are as follows:
Years Ended
January 30, 2026January 31, 2025February 2, 2024
Weighted-average assumptions used:
Expected volatility25.4 %27.1 %29.3 %
Dividend yield1.97 %1.77 %2.10 %
Risk-free interest rate3.82 %4.49 %3.83 %
Expected term, in years2.832.832.82
Schedule of Performance Share Units Activity
Transactions related to performance share units classified as equity awards for the fiscal year ended January 30, 2026, are summarized as follows:
(in thousands, except per share data)
Units1
Weighted-Average Grant-Date Fair Value Per Unit
Nonvested as of January 31, 2025454 $227.46 
Granted146 225.57 
Vested(126)200.06 
Canceled or forfeited(24)217.78 
Nonvested as of January 30, 2026450 $235.07 
1    As of January 30, 2026, the maximum number of nonvested units that could vest under the provisions of the agreements was 0.9 million.
Schedule of Restricted Stock Unit Activity
Transactions related to restricted stock units for the fiscal year ended January 30, 2026, are summarized as follows:
(in thousands, except per share data)SharesWeighted-Average Grant-Date Fair Value Per Share
Nonvested as of January 31, 2025452 $213.52 
Granted292 221.68 
Vested(214)206.24 
Canceled or forfeited(59)219.93 
Nonvested as of January 30, 2026471 $221.09